for intravenous use Initial U.S. Approval: 2023
Lecanemab-irmb injection is “used to treat Alzheimer’s disease“. LEQEMBI for injection is a “prescription medicine”. It is available in “form and strength” Tablets: 10 mg, 50 mg, 100 mg. LEQEMBI Injection can be obtained in India upon request.
To inquire about the LEQEMBI (lecanemab-irmb) injection“ offer price in India”, “shipping process”, and the “estimated time of availability in India”, please get in touch at +91 9891 296 838 (Mr. Tarun) / +91 9811 747 774 (Mr. Neeraj). with the IPN Delhi healthcare team for further discussion.”
Facts about your medicine
DOSAGE FORMS AND STRENGTHS: Package
• 500 mg/5 mL (100 mg/mL) solution in a single-dose vial.
• 200 mg/2 mL (100 mg/mL) solution in a single-dose vial.
DISEASE INDICATIONS: Alzheimer’s disease
MANUFACTURER: Eisai Europe Ltd
MEDICINE APPROVED BY: Food and Drug Administration (FDA)
- Full prescribing information [FDA]: (PDF) Click Here
- FDA grants accelerated approval for Alzheimer’s disease treatment FDA, January 2023